These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Splenectomy for splenomegaly and secondary hypersplenism. Coon WW World J Surg; 1985 Jun; 9(3):437-43. PubMed ID: 4013357 [No Abstract] [Full Text] [Related]
9. Symptomatic splenomegaly in polycythemia vera: a review of the indications for splenectomy and perioperative considerations. Logan MS; Watson CM; Nottingham JM Am Surg; 2009 May; 75(5):363-8. PubMed ID: 19445284 [TBL] [Abstract][Full Text] [Related]
10. Splenectomy in myeloid metaplasia. Cabot EB; Brennan MF; Rosenthal DS; Wilson RE Ann Surg; 1978 Jan; 187(1):24-30. PubMed ID: 74243 [TBL] [Abstract][Full Text] [Related]
11. Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities. Benton CB; Tanaka M; Wilson C; Pierce S; Zhou L; Cortes J; Kantarjian H; Verstovsek S Leuk Res; 2015 Apr; 39(4):419-23. PubMed ID: 25687833 [TBL] [Abstract][Full Text] [Related]
12. Myeloproliferative disorders. Schwartz SI Ann Surg; 1975 Oct; 182(4):464-71. PubMed ID: 1058648 [TBL] [Abstract][Full Text] [Related]
13. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia]. Iványi JL; Marton E; Plander M Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365 [TBL] [Abstract][Full Text] [Related]
14. [Surgery in oncohematology: state of the art]. Marmont AM; Spagliardi E; Abbo L; Longo A; Torelli P Minerva Chir; 1989 Feb; 44(4):643-6. PubMed ID: 2654737 [No Abstract] [Full Text] [Related]
15. [Myeloproliferative disorders]. Hartwich G; Lutz H Med Klin; 1972 Feb; 67(6):183-9. PubMed ID: 4503295 [No Abstract] [Full Text] [Related]
16. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders. Talarico L; Wolf BC; Kumar A; Weintraub LR Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585 [TBL] [Abstract][Full Text] [Related]
17. Polycythemia vera with myelofibrosis and myeloid metaplasia. Acute hepatic failure following splenectomy. McBrine PA; Miller A; Zimelman AP; Koff RS Am J Clin Pathol; 1980 Nov; 74(5):693-6. PubMed ID: 7446477 [TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial. Gowin K; Jain T; Kosiorek H; Tibes R; Camoriano J; Palmer J; Mesa R Leuk Res; 2017 Mar; 54():73-77. PubMed ID: 28113109 [TBL] [Abstract][Full Text] [Related]
19. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia. Petroianu A Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088 [TBL] [Abstract][Full Text] [Related]